CIRCULATING SOLUBLE LOW DENSITY LIPOPROTEIN RECEPTOR LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS BEFORE AND AFTER STATIN THERAPY

被引：0
|
作者：
Ooi, Teik C. [1 ]
Gaudet, Daniel [2 ]
Brisson, Diane [2 ]
Tepliakova, Lioudmila [3 ]
Figeys, Daniel [3 ]
Mayne, Janice [3 ]
机构：
[1] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Div Endocrinol & Metab, Ottawa, ON, Canada
[2] Univ Montreal, Dept Med, Ecogene 21, Montreal, PQ, Canada
[3] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON, Canada
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2018年 / 32卷
关键词：
D O I：
10.1016/j.atherosclerosissup.2018.04.182
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P1.089
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [31] Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report
    Zenti, M. G.
    Stefanutti, C.
    Sanga, V.
    Altomari, A.
    Fabris, A.
    Dauriz, M.
    Bonora, E.
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (04) : 546 - 550
  • [32] Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia
    Maugeais, C
    Ouguerram, K
    Frénais, R
    Maugère, P
    Charbonnel, B
    Magot, T
    Krempf, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1679 - 1686
  • [33] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, Hayato
    Nomura, Akihiro
    Nohara, Atsushi
    Usui, Soichiro
    Sakata, Kenji
    Hayashi, Kenshi
    Fujino, Noboru
    Takamura, Masayuki
    Kawashiri, Masa-aki
    ATHEROSCLEROSIS, 2023, 371 : 61 - 66
  • [34] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, H.
    Nomura, A.
    Usui, S.
    Sakata, K.
    Takamura, M.
    Kawashiri, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [35] Two mutations in the same low-density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia
    Jensen, HK
    Jensen, TG
    Faergeman, O
    Jensen, LG
    Andresen, BS
    Corydon, MJ
    Andreasen, PH
    Hansen, PS
    Heath, F
    Bolund, L
    Gregersen, N
    HUMAN MUTATION, 1997, 9 (05) : 437 - 444
  • [36] Heterozygous familial hypercholesterolemia in children: Low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations
    Torres, AL
    Moorjani, S
    Vohl, MC
    Gagne, C
    Lamarche, B
    Brun, LD
    Lupien, PJ
    Despres, JP
    ATHEROSCLEROSIS, 1996, 126 (01) : 163 - 171
  • [37] The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein(a) levels in familial hypercholesterolemia
    Tonstad, S
    Sundt, E
    Ose, L
    Hagve, TA
    Fruchart, JC
    Bard, JM
    Eden, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (11): : 1415 - 1421
  • [38] Low-density lipoprotein receptor gene mutations diagnose familial hypercholesterolemia
    Nature Reviews Cardiology, 2009, 6 (3) : 161 - 162
  • [39] Mutations in the low density lipoprotein receptor gene in Japanese patients with familial hypercholesterolemia
    Hirosaki Univ Sch of Medicine, Second Dep of Internal Medicine (Publ by New York Acad of Sciences, New York, NY, USA):
  • [40] LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA FIBROBLASTS
    SEMENKOVICH, CF
    OSTLUND, RE
    LEVY, RA
    OSA, SR
    ARTERIOSCLEROSIS, 1981, 1 (05): : A386 - A386
12345